Newsroom
START Dublin will offer patients with advanced cancer the opportunity to participate in cutting edge research and enhance the availability of new cancer drugs 14 October 2024 The Minister for Public Expenditure, NDP Delivery and Reform, Paschal Donohoe TD has today (Monday) officially opened START Dublin, the Republic of Ireland’s
San Antonio, TX – October 8, 2024. The START Center for Cancer Research (“START”) proudly announces that Amita Patnaik, MD, FRCPC, has been named to the prestigious PharmaVoice 100 list as a “Cancer Care Visionary.” This annual award celebrates inspiring individuals in life sciences who are making a profound impact
Dr. Takimoto to propel scientific and medical strategies and advance START’s leadership in global early-phase cancer research San Antonio, TX – October 2, 2024. The START Center for Cancer Research (“START”) proudly announces the appointment of Chris H. Takimoto, MD, PhD, FACP, as its new Chief Medical Officer. Dr. Takimoto,
New Series Unites Global Experts to Explore the Future of Oncology Research in Community Settings San Antonio, TX – August 29, 2024. The START Center for Cancer Research (“START”), the largest global network of fully dedicated, community-based, early-phase oncology clinical trial sites, is proud to announce the launch of its
New START early-phase clinical trial site brings advanced cancer research to Northwell’s Cancer Institute New Hyde Park, NY / San Antonio, TX – May 31, 2024. Northwell Health, New York State’s largest health care provider, and The START Center for Cancer Research (“START”), renowned for being the largest global network
The START Center for Cancer Research (“START”) is set to have a significant presence at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting. Known for our commitment to the advancement of cancer research and treatment, we are excited to share that our team of Principal Investigators (PIs) will
